Olema Pharmaceuticals (OLMA) Stock: Buy, Sell, or Hold?
OLMA - Olema Pharmaceuticals, Inc. Common Stock
$8.23
-0.04 (-0.54%)
▼
5d:
-6.0%
30d:
-24.05%
90d:
-35.59%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When OLMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OLMA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OLMA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OLMA is currently trading at $8.22, which is considered oversold relative to its 30-day fair value range of $9.22 to $10.78.
Technical Outlook: Technically, OLMA is in a downtrend. The price is currently testing key support at $8.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OLMA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.50 (+343.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OLMA is in a downtrend. The price is currently testing key support at $8.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OLMA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.50 (+343.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.22 -
$10.78
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding OLMA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 343.8% below Wall St target ($36.50)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.22 -
$10.78
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.10
Resistance Level
$10.13
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.12
Wall Street Target
$36.50
(+343.8%)
Share & Embed Analysis
Last updated: October 03, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OLMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 55 HOLD |
Advanced OLMA Option Strategies
Professional options setups generated by AI based on today's OLMA price and gamma walls.
